Preparation of gelatin hydrogels incorporating small interfering RNA for the controlled release

References

• Andrieu-Soler C, Doat M, Halhal M, Keller N, Jonet L, BenEzra D, Behar-Cohen F. (2006). Enhanced oligonucleotide delivery to mouse retinal cells using iontophoresis. Mol Vis, 12, 1098–1107.
   PubMed Web of Science ®Google Scholar
• Doi N, Jo JI, Tabata Y. (2011). Preparation of biodegradable gelatin nanospheres with a narrow size distribution for carrier of cellular internalization of plasmid DNA. J Biomater Sci Polym Ed, 23, 991–1004.
   Web of Science ®Google Scholar
• Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2, 161–174.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806–811.
   PubMed Web of Science ®Google Scholar
• Gilbert DF, Erdmann G, Zhang X, Fritzsche A, Demir K, Jaedicke A, Muehlenberg K, Wanker EE, Boutros M. (2011). A novel multiplex cell viability assay for high-throughput RNAi screening. PLoS ONE, 6, e28338.
   PubMedGoogle Scholar
• Gong H, Liu CM, Liu DP, Liang CC. (2005). The role of small RNAs in human diseases: potential troublemaker and therapeutic tools. Med Res Rev, 25, 361–381.
   PubMed Web of Science ®Google Scholar
• Holland TA, Tessmar JK, Tabata Y, Mikos AG. (2004). Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release, 94, 101–114.
   PubMed Web of Science ®Google Scholar
• Jacobson GB, Gonzalez-Gonzalez E, Spitler R, Shinde R, Leake D, Kaspar RL, Contag CH, Zare RN. (2010). Biodegradable nanoparticles with sustained release of functional siRNA in skin. J Pharm Sci, 99, 4261–4266.
   PubMed Web of Science ®Google Scholar
• Jensen DK, Jensen LB, Koocheki S, Bengtson L, Cun D, Nielsen HM, Foged C. (2012). Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release, 157, 141–148.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Ishii A, Miyata K, Lee Y, Wu S, Oba M, Nishiyama N, Kataoka K. (2010). Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown. J Control Release, 145, 141–148.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Miyazaki N, Hayashi N, Otsuru S, Tamai K, Kaneda Y, Tabata Y. (2010). Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng Part A, 16, 1263–1270.
   PubMed Web of Science ®Google Scholar
• Kohara H, Tabata Y. (2011). Enhancement of ectopic osteoid formation following the dual release of bone morphogenetic protein 2 and Wnt1 inducible signaling pathway protein 1 from gelatin sponges. Biomaterials, 32, 5726–5732.
   PubMed Web of Science ®Google Scholar
• Krebs MD, Jeon O, Alsberg E. (2009). Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. J Am Chem Soc, 131, 9204–9206.
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. (2004). Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres. Pharm Res, 21, 1109–1118.
   PubMed Web of Science ®Google Scholar
• Le Pecq JB, Paoletti C. (1966). A new fluorometric method for RNA and DNA determination. Anal Biochem, 17, 100–107.
   PubMed Web of Science ®Google Scholar
• Lin X, Jo H, Ishii TM, Fujita M, Fu M, Tambara K, Yamamoto M, Tabata Y, Komeda M, Matsuoka S. (2009). Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats. Circ J, 73, 2315–2321.
   PubMed Web of Science ®Google Scholar
• Lobovkina T, Jacobson GB, Gonzalez-Gonzalez E, Hickerson RP, Leake D, Kaspar RL, Contag CH, Zare RN. (2011). In vivo sustained release of siRNA from solid lipid nanoparticles. ACS Nano, 5, 9977–9983.
   PubMed Web of Science ®Google Scholar
• Marshall E. (2002). Gene therapy. What to do when clear success comes with an unclear risk? Science, 298, 510–511.
   PubMed Web of Science ®Google Scholar
• Matsumoto G, Kushibiki T, Kinoshita Y, Lee U, Omi Y, Kubota E, Tabata Y. (2006). Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci, 97, 313–321.
   PubMed Web of Science ®Google Scholar
• Nagane K, Kitada M, Wakao S, Dezawa M, Tabata Y. (2009). Practical induction system for dopamine-producing cells from bone marrow stromal cells using spermine-pullulan-mediated reverse transfection method. Tissue Eng Part A, 15, 1655–1665.
   PubMed Web of Science ®Google Scholar
• Nelson CE, Gupta MK, Adolph EJ, Shannon JM, Guelcher SA, Duvall CL. (2012). Sustained local delivery of siRNA from an injectable scaffold. Biomaterials, 33, 1154–1161.
   PubMed Web of Science ®Google Scholar
• Newman CM, Bettinger T. (2007). Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther, 14, 465–475.
   PubMed Web of Science ®Google Scholar
• Obata Y, Nishino T, Kushibiki T, Tomoshige R, Xia Z, Miyazaki M, Abe K, Koji T, Tabata Y, Kohno S. (2012). HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice. Acta Biomater, 8, 2688–2696.
   PubMed Web of Science ®Google Scholar
• Ratanavaraporn J, Furuya H, Kohara H, Tabata Y. (2011). Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials, 32, 2797–2811.
   PubMed Web of Science ®Google Scholar
• Reed SD, Li S. (2009). Electroporation advances in large animals. Curr Gene Ther, 9, 316–326.
   PubMed Web of Science ®Google Scholar
• Rye PD, Stigbrand T. (2004). Interfering with cancer: a brief outline of advances in RNA interference in oncology. Tumour Biol, 25, 329–336.
   PubMed Web of Science ®Google Scholar
• Saito T, Tabata Y. (2012). Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy. Acta Biomater, 8, 646–652.
   PubMed Web of Science ®Google Scholar
• Tabata Y, Nagano A, Ikada Y. (1999). Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng, 5, 127–138.
   PubMedGoogle Scholar
• Tabata Y, Miyao M, Inamoto T, Ishii T, Hirano Y, Yamaoki Y, Ikada Y. (2000). De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. Tissue Eng, 6, 279–289.
   PubMedGoogle Scholar
• Tanigo T, Takaoka R, Tabata Y. (2010). Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration. J Control Release, 143, 201–206.
   PubMed Web of Science ®Google Scholar
• Tuzmen S, Tuzmen P, Arora S, Mousses S, Azorsa D. (2011). RNAi-based functional pharmacogenomics. Methods Mol Biol, 700, 271–290.
   PubMedGoogle Scholar
• Xia H, Mao Q, Paulson HL, Davidson BL. (2002). siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol, 20, 1006–1010.
   PubMed Web of Science ®Google Scholar
• Zamore PD, Tuschl T, Sharp PA, Bartel DP. (2000). RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101, 25–33.
   PubMed Web of Science ®Google Scholar